WHR
37
-6
BBY
53
5
MRK
43
2
FTI
58
7
WMB
62
3
PG
68
2
WYNN
38
4
TRV
56
7
HPE
69
19
GME
97
3
PFE
48
3
SLG
55
5
STT
71
3
CVX
31
3
WU
14
2
HST
34
2
JPM
70
4
MAS
58
4
MCK
75
2
XRAY
29
7
WHR
37
-6
BBY
53
5
MRK
43
2
FTI
58
7
WMB
62
3
PG
68
2
WYNN
38
4
TRV
56
7
HPE
69
19
GME
97
3
PFE
48
3
SLG
55
5
STT
71
3
CVX
31
3
WU
14
2
HST
34
2
JPM
70
4
MAS
58
4
MCK
75
2
XRAY
29
7
Financhill
Back

Lineage Cell Therapeutics Stock Predictions

Not Meta. Not Google. AI 2.0 Is Here, And It's Still Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
55

LCTX
Lineage Cell Therapeutics

Last Price:
$0.65
Seasonality Move:
-5.51%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Lineage Cell Therapeutics Stock Forecast

  • Is Lineage Cell Therapeutics Stock Undervalued?
    The current Lineage Cell Therapeutics [LCTX] share price is $0.68. The Score for LCTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • LCTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Lineage Cell Therapeutics Stock Go Up Next Year?

Data Unavailable

Lineage Cell Therapeutics Stock Rating

Data Unavailable

Lineage Cell Therapeutics Stock Price History

Is LCTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lineagecell.com

52-Week Data

52-Week High:
1.15
52-Week Low:
0.37

Prediction Charts

Market Cap:
155.9M
Price in USD:
0.68
Volume:
2.4M
Beta:
1.26

Technical Analysis

SMA50:
0.47
SMA100:
0.53
SMA200:
0.67
52-Wk Change:
-34.96%

Stock Predictions

  • Is Lineage Cell Therapeutics stock public?
    Yes, Lineage Cell Therapeutics is a publicly traded company.
  • What is the Lineage Cell Therapeutics stock quote today?
    The Lineage Cell Therapeutics stock price is 0.68 USD today.
  • How to buy Lineage Cell Therapeutics stock online?
    You can buy Lineage Cell Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 0.43 0.44 0.44 0.43
May-8 0.43 0.47 0.48 0.43
May-9 0.47 0.44 0.47 0.44
May-12 0.46 0.48 0.49 0.45
May-13 0.47 0.47 0.48 0.45
May-14 0.47 0.46 0.49 0.46
May-15 0.46 0.47 0.47 0.45
May-16 0.47 0.46 0.49 0.46
May-19 0.46 0.50 0.50 0.45
May-20 0.50 0.49 0.50 0.49
May-21 0.49 0.51 0.51 0.48
May-22 0.51 0.51 0.51 0.51
May-23 0.51 0.51 0.51 0.51
May-27 0.66 0.68 0.76 0.66

Lineage Cell Therapeutics Earnings

Data Unavailable

Lineage Cell Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.

* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.